• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同国家的门诊胃肠外抗生素治疗(OPAT):一项比较。

Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison.

作者信息

Esposito S, Noviello S, Leone S, Tice A, Seibold G, Nathwani D, Scaglione F

机构信息

Department of Infectious Diseases, University of Naples, Ospedale Gesù e Maria, Via Cotugno 1, 80135 Naples, Italy.

出版信息

Int J Antimicrob Agents. 2004 Nov;24(5):473-8. doi: 10.1016/j.ijantimicag.2004.06.004.

DOI:10.1016/j.ijantimicag.2004.06.004
PMID:15519480
Abstract

In order to assess how outpatient parenteral antibiotic therapy (OPAT) is managed in different countries, we analyzed the data collected in the USA, UK and Italy by the International OPAT Registry using an ad hoc Access/Excel Microsoft program. The analysis of data concerned 9826 patients in the USA, 981 in the UK and 620 in Italy. Differences were observed in several aspects of OPAT management such as the infections treated and the antibiotics utilized. The duration of therapy also differed: it was much longer in Italy (56.0 average days), than in the USA (22.5 days) and UK (19.9 days). Delivery model, delivery route and infusion devices show substantial differences. The present analysis shows that OPAT is carried out with substantial differences in different countries probably according to different programmes and guidelines adopted.

摘要

为评估不同国家门诊胃肠外抗生素治疗(OPAT)的管理情况,我们使用专门的Microsoft Access/Excel程序,分析了国际OPAT注册中心在美国、英国和意大利收集的数据。数据分析涉及美国的9826例患者、英国的981例患者和意大利的620例患者。在OPAT管理的几个方面观察到差异,如治疗的感染类型和使用的抗生素。治疗持续时间也有所不同:意大利(平均56.0天)比美国(22.5天)和英国(19.9天)长得多。给药模式、给药途径和输液装置存在显著差异。目前的分析表明,不同国家开展OPAT时可能根据所采用的不同方案和指南存在显著差异。

相似文献

1
Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison.不同国家的门诊胃肠外抗生素治疗(OPAT):一项比较。
Int J Antimicrob Agents. 2004 Nov;24(5):473-8. doi: 10.1016/j.ijantimicag.2004.06.004.
2
Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years' experience at a UK centre.英国某中心 4 年经验回顾:感染性心内膜炎的门诊患者肠外抗生素治疗。
Postgrad Med J. 2012 Jul;88(1041):377-81. doi: 10.1136/postgradmedj-2011-130355. Epub 2012 Feb 25.
3
International outpatient parenteral antimicrobial therapy.国际门诊胃肠外抗菌治疗。
Int J Clin Pract Suppl. 2000 Dec(115):26.
4
Ertapenem: a new opportunity for outpatient parenteral antimicrobial therapy.厄他培南:门诊胃肠外抗菌治疗的新契机。
J Antimicrob Chemother. 2004 Jun;53 Suppl 2:ii83-6. doi: 10.1093/jac/dkh210.
5
Outpatient parenteral antibiotic therapy in Singapore.新加坡的门诊胃肠外抗生素治疗。 (你原文中的“parenteral”疑似有误,正确的可能是“parenteral”,意为“胃肠外的” ,我按照纠正后的意思翻译,若有误请根据实际情况调整 )
Int J Antimicrob Agents. 2006 Dec;28(6):545-50. doi: 10.1016/j.ijantimicag.2006.08.018. Epub 2006 Nov 13.
6
A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.门诊肠外抗生素治疗(OPAT)的成本分析:亚洲视角
Int J Antimicrob Agents. 2009 Jan;33(1):46-51. doi: 10.1016/j.ijantimicag.2008.07.016. Epub 2008 Sep 26.
7
Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center.多学科团队对潜在门诊患者出院前接受静脉用抗菌药物治疗的方案评估对出院后抗菌药物使用的影响:来自一家学术医疗中心的回顾性研究
Ann Pharmacother. 2011 Nov;45(11):1329-37. doi: 10.1345/aph.1Q240. Epub 2011 Oct 11.
8
[Outpatient Parenteral Antibiotic Therapy (OPAT): the Italian registry].[门诊胃肠外抗生素治疗(OPAT):意大利登记处]
Infez Med. 2002 Sep;10(3):169-75.
9
Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.门诊胃肠外抗菌治疗(OPAT):对选定患者而言,在家自行给药是否安全?一项针对超过13年的大型队列的回顾性分析
J Antimicrob Chemother. 2007 Aug;60(2):356-62. doi: 10.1093/jac/dkm210. Epub 2007 Jun 11.
10
Outpatient parenteral antimicrobial therapy today.今日门诊患者的肠外抗菌治疗。
Clin Infect Dis. 2010 Sep 15;51 Suppl 2:S198-208. doi: 10.1086/653520.

引用本文的文献

1
Delivery of Outpatient Parenteral Antimicrobial Therapy (OPAT) in an Ever-Changing National Health Service (UK): Benefits, Barriers, and Opportunities.在不断变化的英国国民医疗服务体系中提供门诊肠外抗菌治疗(OPAT):益处、障碍与机遇
Antibiotics (Basel). 2025 Apr 29;14(5):451. doi: 10.3390/antibiotics14050451.
2
Exploring patients' perspectives: a mixed methods study on Outpatient Parenteral Antimicrobial Therapy (OPAT) experiences.探索患者视角:门诊肠外抗菌治疗(OPAT)体验的混合方法研究。
BMC Health Serv Res. 2024 Apr 29;24(1):544. doi: 10.1186/s12913-024-11017-9.
3
Left ventricular assist device-associated driveline infections as a specific form of complicated skin and soft tissue infection/acute bacterial skin and skin structure infection - issues and therapeutic options.
左心室辅助装置相关的移植物感染作为一种特定类型的复杂性皮肤和软组织感染/急性细菌性皮肤和皮肤结构感染 - 问题和治疗选择。
Curr Opin Infect Dis. 2024 Apr 1;37(2):95-104. doi: 10.1097/QCO.0000000000000999. Epub 2024 Jan 15.
4
Exploring the advancements of Australian OPAT.探索澳大利亚门诊静脉抗生素治疗的进展。
Ther Adv Infect Dis. 2023 Sep 21;10:20499361231199582. doi: 10.1177/20499361231199582. eCollection 2023 Jan-Dec.
5
Cinnamaldehyde Restores Ceftriaxone Susceptibility against Multidrug-Resistant .肉桂醛恢复头孢曲松对多重耐药
Int J Mol Sci. 2023 May 26;24(11):9288. doi: 10.3390/ijms24119288.
6
Outpatient Parenteral Antimicrobial Therapy Practice in United Kingdom: A Single-center Experience.英国门诊胃肠外抗菌治疗实践:单中心经验
Oman Med J. 2022 Nov 30;37(6):e442. doi: 10.5001/omj.2023.26. eCollection 2022 Nov.
7
Assessment of risk factors associated with outpatient parenteral antimicrobial therapy (OPAT) complications: A retrospective cohort study.门诊胃肠外抗菌治疗(OPAT)并发症相关危险因素评估:一项回顾性队列研究。
Antimicrob Steward Healthc Epidemiol. 2022 Nov 11;2(1):e183. doi: 10.1017/ash.2022.313. eCollection 2022.
8
Evaluate the Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) Program in Saudi Arabia: A Retrospective Study.评估沙特阿拉伯门诊胃肠外抗菌治疗(OPAT)项目的有效性:一项回顾性研究。
Antibiotics (Basel). 2022 Mar 24;11(4):441. doi: 10.3390/antibiotics11040441.
9
[Rare etiology of a perinephric abscess].[肾周脓肿的罕见病因]
Urologie. 2022 Sep;61(9):986-991. doi: 10.1007/s00120-022-01808-5. Epub 2022 Apr 11.
10
Consumption of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in the community, European Union/European Economic Area, 1997-2017.社区内四环素类、磺胺类和甲氧苄啶以及其他抗菌药物的消费情况,欧盟/欧洲经济区,1997-2017 年。
J Antimicrob Chemother. 2021 Jul 26;76(12 Suppl 2):ii45-ii59. doi: 10.1093/jac/dkab177.